Stock COO THE COOPER COMPANIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials The Cooper Companies, Inc.

Equities

COO

US2166485019

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
94.33 USD +4.54% Intraday chart for The Cooper Companies, Inc. -0.59% -0.30%
May. 31 Jefferies Adjusts Price Target on Cooper Companies to $107 From $105 MT
May. 31 Baird Adjusts Price Target on Cooper Companies to $118 From $116 MT

Valuation

Fiscal Period: October 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 14,426 15,646 20,556 13,491 15,439 18,745 - -
Enterprise Value (EV) 1 16,163 17,324 21,939 16,116 17,889 21,068 20,443 19,865
P/E ratio 31.2 x 66.3 x 7.05 x 35.2 x 52.7 x 43.7 x 31.2 x 26.6 x
Yield 0.02% 0.02% 0.01% 0.02% 0.02% 0.06% 0.08% 0.09%
Capitalization / Revenue 5.44 x 6.44 x 7.03 x 4.08 x 4.3 x 4.83 x 4.52 x 4.25 x
EV / Revenue 6.09 x 7.13 x 7.51 x 4.87 x 4.98 x 5.42 x 4.93 x 4.5 x
EV / EBITDA 18.2 x 24.1 x 23.6 x 17 x 14.7 x 18.2 x 16.1 x 14.5 x
EV / FCF 38.4 x 98.3 x 41.9 x 35.8 x 83.2 x 53.5 x 32.6 x 26.1 x
FCF Yield 2.61% 1.02% 2.39% 2.79% 1.2% 1.87% 3.06% 3.82%
Price to Book 4.01 x 4.14 x 2.99 x 1.89 x 2.04 x 2.35 x 2.2 x 2.05 x
Nbr of stocks (in thousands) 198,294 196,162 197,216 197,384 198,097 198,756 - -
Reference price 2 72.75 79.76 104.2 68.35 77.94 94.31 94.31 94.31
Announcement Date 12/5/19 12/3/20 12/2/21 12/8/22 12/7/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: October 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,653 2,431 2,922 3,308 3,593 3,884 4,148 4,412
EBITDA 1 886.2 719.9 930.9 948.9 1,218 1,154 1,266 1,372
EBIT 1 732.2 570 767.7 782.3 850.8 944.5 1,033 1,131
Operating Margin 27.59% 23.45% 26.27% 23.65% 23.68% 24.32% 24.9% 25.62%
Earnings before Tax (EBT) 1 477.4 266.5 491.5 475.3 412.9 557.6 711.2 850.2
Net income 1 466.7 238.4 2,945 385.8 294.2 451.6 593.7 702.7
Net margin 17.59% 9.81% 100.76% 11.66% 8.19% 11.63% 14.31% 15.93%
EPS 2 2.332 1.202 14.79 1.940 1.478 2.160 3.022 3.541
Free Cash Flow 1 421.1 176.2 524.2 450.4 215 394 626.5 759.7
FCF margin 15.87% 7.25% 17.94% 13.61% 5.98% 10.14% 15.1% 17.22%
FCF Conversion (EBITDA) 47.52% 24.48% 56.31% 47.47% 17.64% 34.13% 49.48% 55.36%
FCF Conversion (Net income) 90.23% 73.91% 17.8% 116.74% 73.08% 87.24% 105.52% 108.12%
Dividend per Share 2 0.0150 0.0150 0.0150 0.0150 0.0150 0.0600 0.0775 0.0862
Announcement Date 12/5/19 12/3/20 12/2/21 12/8/22 12/7/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: October 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 759.1 787.2 829.8 843.4 848.1 858.5 877.4 930.2 927.1 931.6 942.6 996.8 1,010 991.5 1,010
EBITDA 1 230.3 233.5 245.5 238.8 231.2 237.4 254 317.1 319.2 - 273.1 292.5 305.9 306.1 305
EBIT 1 189 193.8 203.2 197.2 188.2 194.2 207.5 222.6 226.5 227.1 224.8 240.3 252.4 243.3 245.7
Operating Margin 24.9% 24.62% 24.49% 23.38% 22.19% 22.62% 23.65% 23.93% 24.43% 24.38% 23.85% 24.1% 24.98% 24.54% 24.33%
Earnings before Tax (EBT) 1 121.6 121.9 163.7 117.3 72.4 122.1 65.6 118.8 106.4 120 130 163 177.2 170.8 168.5
Net income 1 110.3 95.3 126.6 98.4 65.6 84.6 39.8 85.3 84.5 81.2 88.9 136.1 144 150.6 150.9
Net margin 14.53% 12.11% 15.26% 11.67% 7.73% 9.85% 4.54% 9.17% 9.11% 8.72% 9.43% 13.65% 14.26% 15.19% 14.95%
EPS 2 0.5525 0.4775 0.6375 0.4950 0.3300 0.4250 0.2000 0.4275 0.4250 0.4100 0.4400 0.6629 0.7043 0.7533 0.7533
Dividend per Share 0.007500 - - - - - - - - - - - - - -
Announcement Date 12/2/21 3/3/22 6/2/22 8/31/22 12/8/22 3/2/23 6/1/23 8/30/23 12/7/23 2/29/24 5/30/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: October 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,737 1,677 1,383 2,625 2,450 2,324 1,698 1,121
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.96 x 2.33 x 1.486 x 2.767 x 2.011 x 2.013 x 1.342 x 0.8166 x
Free Cash Flow 1 421 176 524 450 215 394 626 760
ROE (net income / shareholders' equity) 13.5% 6.4% 12.2% 8.75% 8.66% 9.05% 9.4% 9.62%
ROA (Net income/ Total Assets) 7.54% 3.66% 8.06% 5.85% 5.51% 6.4% 6% 6.25%
Assets 1 6,194 6,506 36,521 6,593 5,338 7,057 9,895 11,243
Book Value Per Share 2 18.10 19.30 34.80 36.10 38.10 40.10 42.80 45.90
Cash Flow per Share 2 3.570 2.450 3.710 3.480 3.050 3.480 5.060 5.800
Capex 1 292 310 214 242 393 411 361 339
Capex / Sales 11.01% 12.77% 7.34% 7.31% 10.92% 10.59% 8.69% 7.69%
Announcement Date 12/5/19 12/3/20 12/2/21 12/8/22 12/7/23 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
94.31 USD
Average target price
108.2 USD
Spread / Average Target
+14.68%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

1st Jan change Capi.
THE COOPER COMPANIES, INC. Stock The Cooper Companies, Inc.
-0.30% 18.75B
ESSILORLUXOTTICA Stock EssilorLuxottica
+13.05% 101B
ALCON INC. Stock Alcon Inc.
+22.39% 43.96B
AUTEK CHINA INC. Stock Autek China Inc.
-20.50% 2.22B
WARBY PARKER INC. Stock Warby Parker Inc.
+25.60% 2.11B
PEGAVISION CORPORATION Stock Pegavision Corporation
+19.17% 1.13B
MINGYUE OPTICAL LENS CO.,LTD. Stock Mingyue Optical Lens Co.,Ltd.
-38.32% 716M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. Stock Universal Vision Biotechnology Co., Ltd.
-10.65% 645M
MENICON CO., LTD. Stock Menicon Co., Ltd.
-44.53% 632M
SHANGHAI CONANT OPTICAL CO., LTD. Stock Shanghai Conant Optical Co., Ltd.
+57.22% 606M
Glasses, Spectacles & Contact Lenses
  1. Stock Market
  2. Equities
  3. COO Stock
  4. Financials The Cooper Companies, Inc.